Literature DB >> 14007482

A simple and reliable subclassification of chronic schizophrenia.

J K WING.   

Abstract

Entities:  

Keywords:  SCHIZOPHRENIA/psychology

Mesh：

Year:  1961        PMID： 14007482     DOI： 10.1192/bjp.107.450.862

Source DB:  PubMed          Journal:  J Ment Sci        ISSN： 0368-315X


× No keyword cloud information.
  32 in total

1.  Work performance versus clinical assessment in the evaluation of phenothiazine therapy.

Authors:  P Harper; C Chacon
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  A comparative trial of the decanoates of flupenthixol and fluphenazine.

Authors:  M Hamilton; I R Card; G G Wallis; M R Mahmoud
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

3.  Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.

Authors:  O Gureje
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

4.  Assessment of drugs in schizophrenia. Discussion on assessment of psychiatric and social state.

Authors:  U Malm
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

Review 5.  SCAN and the PSE tradition.

Authors:  J Wing
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1996-03       Impact factor: 4.328

6.  Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.

Authors:  Shaun M Eack; Deborah P Greenwald; Susan S Hogarty; Susan J Cooley; Ann Louise DiBarry; Debra M Montrose; Matcheri S Keshavan
Journal:  Psychiatr Serv       Date:  2009-11       Impact factor: 3.084

Review 7.  The measurement of 'social disablement'. The MRC social behaviour and social role performance schedules.

Authors:  J K Wing
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1989-07       Impact factor: 4.328

8.  A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.

Authors:  D J King; M Blomqvist; S J Cooper; M M Doherty; M J Mitchell; R C Montgomery
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 9.  Trifluoperazine for schizophrenia.

Authors:  L O Marques; M S Lima; B G O Soares
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Antipsychotic treatment with alpha-methyltyrosine in combination with thioridazine: prolactin response and interaction with dopaminergic precursor pools.

Authors:  M Larsson; R Ohman; L Wallin; J Wålinder; A Carlsson
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.